AP
Therapeutic Areas
BillionToOne Pipeline
| Drug | Indication | Phase |
|---|---|---|
| UNITY Complete® | Non-invasive prenatal screening for fetal aneuploidies and recessive single-gene conditions | Approved/Commercial |
| UNITY Fetal Antigen™ (Expanded RBC & Platelet) | Prenatal screening for fetal red blood cell and platelet antigen status | Approved/Commercial |
| Northstar Select® | Pan-cancer liquid biopsy for therapy selection (actionable variants) | Approved/Commercial |
| Northstar Response® | Pan-cancer liquid biopsy for treatment response monitoring | Approved/Commercial |
| Northstar Select® Add-On Applications | Unspecified expanded liquid biopsy applications | Commercial Launch |
| Phase 3 Collaboration with Johnson & Johnson | Unspecified oncology indication | Phase 3 |